From 347,559 IS patients in these hospitals, 42,122 (12.1%) received TE
Impact of medications on COVID-19 outcomes in inflammatory bowel disease: analysis of more than 6000 patients from an international registry
Peptide therapy is not a substitute for sleep, nutrition, exercise, stress management, or appropriate medical care
Evidence within human hypertension is limited, with several indirect biomarkers that are purported to be indicators of gut permeability increased in participants with hypertension
We hypothesized that unlike nitric oxide (NO)-agents, L-NAME and/or L-arginine, the application of the stable gastric pentadecapeptide BPC 157 with its most recent vascular effects (vascular recruitment) means attenuated bowel adhesion formation and NO- and malondialdehyde (MDA)-tissue values